Abstract
Objectives: The consistently observed epidemiologic associations of obesity and physical activity with colorectal cancer and precursor adenoma risk suggest that insulin and glucose control may be contributory. We evaluated the association of glycosylated hemoglobin (HbA1c), a clinical indicator of average glycemia over the previous 2 months, and possibly, indirectly, a marker of average blood insulin level, with colorectal carcinogenesis.
Methods: Among women in the Nurses' Health Study, who provided blood in 1989–90 and were diagnosed subsequently in 1989–94, we included 79 colorectal cancer cases and 156 matched controls, and 201 distal colorectal adenoma cases and 201 matched controls. HbA1c concentrations in red blood cells were determined blindly by turbidometric immunoinhibition. Odds ratios (OR) and 95% confidence intervals (CI) were estimated from conditional logistic regression models.
Results: HbA1c level did not significantly differ between colorectal cancer cases (median 5.5%) and controls (5.5%, p = 0.5), although a small difference between adenoma cases (5.6%) and controls (5.5%, p = 0.06) was noted. Compared to the lowest tertile of HbA1c (median 5.2%), women in the middle (median 5.5%, OR = 1.2, CI = 0.6–2.5) and upper (5.8%, OR = 1.2, CI = 0.6–2.7) tertiles were not at an increased risk for colorectal cancer. A modestly elevated risk of distal colorectal adenoma in the upper (median 5.8%, OR = 1.4, CI = 0.9–2.3) versus lower (median 5.3%) tertile could not be excluded. These associations were not appreciably altered after adjusting for known and suspected colorectal cancer risk factors.
Conclusion: Over the range of levels observed in this relatively small sample of middle-aged women, prediagnostic HbA1c does not clearly predict colorectal cancer and adenoma risk.
Similar content being viewed by others
References
Wu AH, Paganini-Hill A, Ross RK, Henderson BE (1987) Alcohol, physical activity and other risk factors for colorectal cancer: a prospective study. Br J Cancer 55: 687-694.
Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC (1995) Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med 122: 327-334.
Bostick RM, Potter JD, Kushi LH, et al. (1994) Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control 5: 38-52.
Chyou PH, Nomura AMY, Stemmermann GN (1996) A prospective study of colon and rectal cancer among Hawaii Japanese men. Ann Epidemiol 6: 276-282.
Martínez ME, Giovannucci E, Spiegelman D, Hunter DJ, Willett WC, Colditz GA (1997) Leisure-time physical activity, body size, and colon cancer in women. J Natl Cancer Inst 89: 948-955.
Colditz GA, Cannuscio CC, Frazier AL (1997) Physical activity and reduced risk of colon cancer: implications for prevention. Cancer Causes Control 8: 649-667.
Giovannucci E, Colditz GA, Stampfer MJ, Willett WC (1996) Physical activity, obesity and risk of colorectal adenoma in women. Cancer Causes Control 7: 253-263.
Bloomgarden ZT (1998) Insulin resistance — current concepts. Clin Ther 20: 216-231.
Koivisto VA, Yki-Jarvinen H, DeFronzo RA (1988) Physical training and insulin sensitivity. Diabetes Metab Rev 1: 445-481.
La Vecchia C, D'Avanzo B, Negri E, Franceschi S (1991) History of selected diseases and the risk of colorectal cancer. Eur J Cancer 27: 582-586.
Steenland K, Nowlin S, Palu S (1995) Cancer incidence in the National Health and Nutrition Survey I. Follow-up data: diabetes, cholesterol, pulse, and physical activity. Cancer Epidemiol Biomarkers Prev 4: 807-811.
Hardell L, Fredrikson M, Axelson O (1996) Case-control study on colon cancer regarding previous diseases and drug intake. Int J Oncol 8: 439-444.
Fernandez E, La Vecchia C, D'Avanzo B, Negri E, Franceschi S (1997) Risk factors for colorectal cancer in subjects with family history of the disease. Br J Cancer 75: 1381-1384.
La Vecchia C, Negri E, Decarli A, Franceschi S (1997) Diabetes mellitus and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 6: 1007-1010.
Le Marchand L, Wilkens LR, Kolonel LN, Hankin JH, Lyu LC (1997) Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Res 57: 4787-4794.
Weiderpass E, Gridley G, Nyrén O, Ekbom A, Persson I, Adami HO (1997) Diabetes mellitus and risk of large bowel cancer. J Natl Cancer Inst 89: 660-661.
Will JC, Galuska DA, Vinicor F, Calle EE (1998) Colorectal cancer: another complication of diabetes mellitus? Am J Epidemiol 147: 816-825.
Hu FB, Manson JE, Liu S, et al. (1999) Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 91: 542-547.
Adami HO, McLaughlin J, Ekbom A, et al. (1991) Cancer risk in patients with diabetes mellitus. Cancer Causes Control 2: 307-314.
Kono S, Honjo S, Todoroki I, et al. (1998) Glucose intolerance and adenomas of the sigmoid colon in Japanese men (Japan). Cancer Causes Control 9: 441-446.
Yamada K, Araki S, Tamura M, et al. (1998) Relation of serum total cholesterol, serum triglycerides and fasting plasma glucose to colorectal carcinoma in situ. Int J Epidemiol 27: 794-798.
McKeown-Eyssen G (1994) Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 3: 687-695.
Giovannucci E (1995) Insulin and colon cancer. Cancer Causes Control 6: 164-179.
Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Hennekens CH, Speizer FE (1987) Dietary fat and the risk of breast cancer. N Engl J Med 316: 22-28.
Willett WC, Stampfer MJ (1986) Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 124: 17-27.
Grodstein F, Martinez ME, Platz EA, et al. (1998) Postmenopausal hormone use and risk for colorectal cancer and adenoma. Ann Intern Med 128: 705-712.
Slattery ML, Benson J, Berry TD, et al. (1997) Dietary sugar and colon cancer. Cancer Epidemiol Biomarkers Prev 6: 677-685.
Koenuma M, Yamori T, Tsuruo T (1989) Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants for colon carcinoma 26. Jpn J Cancer Res 80: 51-58.
Watkins LF, Lewis LR, Levine AE (1990) Characterization of the synergistic effect of insulin and transferrin and the regulation of their receptors on a human colon carcinoma cell line. Int J Cancer 45: 372-375.
Björk J, Nilsson J, Hultcrantz R, Johansson C (1993) Growth-regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on the non-transformed intestinal epithelial cell line IEC-6 and the colon cancer cell line HT 29. Scand J Gastroenterol 28: 879-884.
Tran TT, Medline A, Bruce WR (1996) Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomarkers Prev 5: 1013-1015.
Corpet DE, Jacquinet C, Peiffer G, Taché S (1997) Insulin injections promote the growth of aberrant crypt foci in the colon of rats. Nutr Cancer 27: 316-320.
McKeown-Eyssen GE, the Toronto Polyp Prevention Group (1996) Insulin resistance and the risk of colorectal neoplasia. Cancer Epidemiol Biomarkers Prev 5: 235.
Riccardi G, Rivellese AA (1991) Effects of dietary fiber and carbohydrate on glucose and lipoprotein metabolism in diabetic patients. Diabetes Care 14: 1115-1125.
Ko GTC, Chan JCN, Woo J, et al. (1998) Glycated haemoglobin and cardiovascular risk factors in Chinese subjects with normal glucose tolerance. Diabet Med 15: 573-578.
Vitelli LL, Shahar E, Heiss G, et al. (1997) Glycosylated hemoglobin level and carotid intimal-medial thickening in nondiabetic individuals. Diabetes Care 20: 1435-1458.
Sosenko JM, Kubrusly DB, Goldberg RB, et al. (1986) High-density lipoprotein and glycosylated hemoglobin in nondiabetic individuals. Arch Intern Med 146: 1521-1524.
Rochman H (1980) Hemoglobin A1c and diabetes mellitus. Ann Clin Lab Sci 10: 111-115.
Gonen B, Rubenstein AH, Rochman H, Tanega SP, Horwitz DL (1977) Haemoglobin A1: An indicator of the metabolic control of diabetic patients. Lancet 2: 734-737.
Theunis L, Neels H, Fischbach F, Miravalles E (1993) Age-dependence, sex-dependence and reference values of HbA1c determined by a new method on Boehringer Mannheim/Hitachi instruments. Klin Lab 39: 1026-1028.
Koschinsky T, Niederau CM, Reinauer H (1993) Assessment of metabolic control in Type 1 and Type 2 diabetic patients with the new Tina-quant® HbA1c assay. Klin Lab 39: 1063-1068.
Singer DE, Nathan DM, Anderson KM, Wilson PWF, Evans JC (1992) Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes 41: 202-208.
Park S, Barrett-Connor E, Wingard D, Shan J, Edelstein S (1996) GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. The Rancho Bernardo Study. Diabetes Care 19: 450-456.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Platz, E.A., Hankinson, S.E., Rifai, N. et al. Glycosylated hemoglobin and risk of colorectal cancer and adenoma (United States). Cancer Causes Control 10, 379–386 (1999). https://doi.org/10.1023/A:1008953611657
Issue Date:
DOI: https://doi.org/10.1023/A:1008953611657